MERSANA THERAPEUTICS
2,2800
29-ноября-24 13:45:00
15 мин. задержка
Акции
+0,0900
+4,11%
Сегодняшний диапазон
2,1550 - 2,3100
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results
13 ноя 2024 07:00:50 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host Third Quarter 2024 Conference Call on November 13, 2024
06 ноя 2024 08:00:49 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results
13 авг 2024 07:00:02 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host Second Quarter 2024 Conference Call on August 13, 2024
06 авг 2024 08:00:14 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Upcoming Investor Conferences
22 май 2024 08:00:49 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results
09 май 2024 06:59:34 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 май 2024 16:30:15 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024
02 май 2024 08:00:42 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 апр 2024 16:30:28 Источник Nasdaq GlobeNewswire
-
28 фев 2024 07:00:08 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Upcoming Investor Conferences
27 фев 2024 08:01:15 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024
21 фев 2024 08:00:22 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics to Participate in Guggenheim’s 6th Annual Biotechnology Conference
01 фев 2024 08:00:46 Источник Nasdaq GlobeNewswire
-
05 янв 2024 08:01:19 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 дек 2023 16:30:01 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results
07 ноя 2023 07:00:55 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host Third Quarter 2023 Conference Call on November 7, 2023
31 окт 2023 16:30:25 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces FDA has Lifted Clinical Hold on Phase 1 Clinical Trial of XMT-2056
31 окт 2023 08:00:01 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Changes in Leadership
06 сен 2023 07:00:40 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Second Quarter 2023 Financial Results
08 авг 2023 08:00:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >